Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs DR. LAL PATHLABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS DR. LAL PATHLABS KRSNAA DIAGNOSTICS/
DR. LAL PATHLABS
 
P/E (TTM) x - 64.9 - View Chart
P/BV x 9.7 22.1 44.1% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 KRSNAA DIAGNOSTICS   DR. LAL PATHLABS
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
DR. LAL PATHLABS
Mar-21
KRSNAA DIAGNOSTICS/
DR. LAL PATHLABS
5-Yr Chart
Click to enlarge
High RsNA2,735 0.0%   
Low RsNA1,305 0.0%   
Sales per share (Unadj.) Rs998.8189.7 526.4%  
Earnings per share (Unadj.) Rs284.535.6 799.7%  
Cash flow per share (Unadj.) Rs342.144.8 763.0%  
Dividends per share (Unadj.) Rs020.00 0.0%  
Avg Dividend yield %NM1.0- 
Book value per share (Unadj.) Rs355.5144.6 245.8%  
Shares outstanding (eoy) m6.5083.34 7.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x010.6 0.0%   
Avg P/E ratio x056.8 0.0%  
P/CF ratio (eoy) x045.1 0.0%  
Price / Book Value ratio x014.0 0.0%  
Dividend payout %056.2 0.0%   
Avg Mkt Cap Rs m0168,365 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2962,737 10.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,49215,813 41.1%  
Other income Rs m122513 23.8%   
Total revenues Rs m6,61516,326 40.5%   
Gross profit Rs m3,4664,363 79.4%  
Depreciation Rs m374772 48.5%   
Interest Rs m259160 162.1%   
Profit before tax Rs m2,9553,944 74.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105979 112.9%   
Profit after tax Rs m1,8492,965 62.4%  
Gross profit margin %53.427.6 193.5%  
Effective tax rate %37.424.8 150.7%   
Net profit margin %28.518.7 151.9%  
BALANCE SHEET DATA
Current assets Rs m2,48111,452 21.7%   
Current liabilities Rs m1,8382,743 67.0%   
Net working cap to sales %9.955.1 18.0%  
Current ratio x1.44.2 32.3%  
Inventory Days Days2521 118.8%  
Debtors Days Days4115 264.6%  
Net fixed assets Rs m3,5644,881 73.0%   
Share capital Rs m2,489833 298.6%   
"Free" reserves Rs m-17811,219 -1.6%   
Net worth Rs m2,31012,053 19.2%   
Long term debt Rs m1,6801 141,137.8%   
Total assets Rs m6,04516,333 37.0%  
Interest coverage x12.425.6 48.3%   
Debt to equity ratio x0.70 736,253.2%  
Sales to assets ratio x1.11.0 110.9%   
Return on assets %34.919.1 182.3%  
Return on equity %80.024.6 325.4%  
Return on capital %80.534.0 236.6%  
Exports to sales %00-   
Imports to sales %00.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA105 0.0%   
Fx inflow Rs m0143 0.0%   
Fx outflow Rs m0105 0.0%   
Net fx Rs m038 0.0%   
CASH FLOW
From Operations Rs m1,0263,982 25.8%  
From Investments Rs m-611-2,120 28.8%  
From Financial Activity Rs m308-1,386 -22.3%  
Net Cashflow Rs m723476 151.9%  

Share Holding

Indian Promoters % 27.4 55.2 49.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 34.6 32.0 108.0%  
FIIs % 4.4 25.5 17.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 44.8 162.2%  
Shareholders   75,065 135,068 55.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   FORTIS HEALTHCARE    INDRAPRASTHA MEDICAL    THYROCARE TECHNOLOGIES    METROPOLIS HEALTHCARE    KOVAI MEDICAL    



Today's Market

Indian Share Markets Trade Lower with Energy Stocks Under Pressure; Infosys, ONGC Top Losers(10:30 am)

Asian stock markets gained ground after a mixed opening today, with some support from bargain-hunting purchases.

Related Views on News

DR. LAL PATHLABS 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DR. LAL PATHLABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the valuation of DR. LAL PATHLABS.

DR. LAL PATHLABS Announces Quarterly Results (1QFY22); Net Profit Up 370.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, DR. LAL PATHLABS has posted a net profit of Rs 1 bn (up 370.8% YoY). Sales on the other hand came in at Rs 6 bn (up 128.0% YoY). Read on for a complete analysis of DR. LAL PATHLABS's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

More Views on News

Most Popular

India's Best Semiconductor Stocks(Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts...(Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Jan 20, 2022 10:40 AM

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 8-QTR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS